|
|
|
|
When selecting a CMO, it’s important to look at organizational alignment, senior leadership engagement, program management, commitment to projects large and small, and processes in place to manage risk.
|
|
|
|
|
As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb. Potential CMO partners should be able to help a medtech understand the implications of its outsourcing needs.
|
|
|
|
|
Utilizing automated manufacturing is a common CMO strategy that can deliver quality, cost savings, and scalability to the manufacture of drug delivery. But to exploit these advantages, it is vital to understand automated manufacturing’s strengths and limitations.
|
|
|
|
|
Scaling point-of-care diagnostics requires integrating microfluidics, chemistry, and automated assembly early in development. Aligning these pillars reduces risk and speeds time-to-market.
|
|
|
|
|
Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.
|
|
|
|
|
Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.
|
|
|
